(+/-)-cis-3-(4-hydroxyphenyl)-4-(4-methoxyphenyl)-3,4-dihydro-2H-cromen-7-ol | |
---|---|
Trade Name | |
Orphan Indication | Metastatic Melanoma |
USA Market Approval | USA |
USA Designation Date | 2008-02-01 00:00:00 |
Sponsor | Marshall Edwards, Inc.;11975 El Camino Real, Suite 101;San Diego, California, 92130 |